BMS-936559
N/A
Report date: 2026/05/20 20:02:01
Base Information
Drug NameBMS-936559
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[14]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[7]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A
Develop Information
Active CompaniesNorwegian University Of Science And Technology
Inactive CompaniesBristol Myers Squibb SrlcompanyThe University Of IowaNational Institute Of Allergy And Infectious Diseases (Niaid)
Active Indications
Inactive Indications +[13]
Other Information
ATC CodeN/A
Related LinksN/A